ANL 34.10 Decreased By ▼ -0.15 (-0.44%)
ASC 13.65 Increased By ▲ 0.30 (2.25%)
ASL 23.40 Increased By ▲ 0.80 (3.54%)
AVN 85.60 Increased By ▲ 1.90 (2.27%)
BOP 7.70 No Change ▼ 0.00 (0%)
BYCO 9.44 Increased By ▲ 0.07 (0.75%)
DGKC 111.51 Increased By ▲ 1.31 (1.19%)
EPCL 48.99 Decreased By ▼ -1.90 (-3.73%)
FCCL 22.85 Increased By ▲ 0.09 (0.4%)
FFBL 25.47 Decreased By ▼ -0.23 (-0.89%)
FFL 15.33 Increased By ▲ 0.03 (0.2%)
HASCOL 8.94 Decreased By ▼ -0.06 (-0.67%)
HUBC 78.43 Decreased By ▼ -0.57 (-0.72%)
HUMNL 6.13 Increased By ▲ 0.29 (4.97%)
JSCL 19.14 Increased By ▲ 0.44 (2.35%)
KAPCO 40.50 Increased By ▲ 1.11 (2.82%)
KEL 3.72 Increased By ▲ 0.04 (1.09%)
LOTCHEM 14.20 Decreased By ▼ -0.15 (-1.05%)
MLCF 42.75 Increased By ▲ 0.45 (1.06%)
PAEL 30.90 Decreased By ▼ -0.17 (-0.55%)
PIBTL 9.52 Increased By ▲ 0.07 (0.74%)
POWER 8.61 Increased By ▲ 0.17 (2.01%)
PPL 82.50 Decreased By ▼ -0.80 (-0.96%)
PRL 23.09 Increased By ▲ 0.32 (1.41%)
PTC 9.00 Decreased By ▼ -0.20 (-2.17%)
SILK 1.38 Decreased By ▼ -0.02 (-1.43%)
SNGP 38.90 Increased By ▲ 0.31 (0.8%)
TRG 165.00 Increased By ▲ 1.78 (1.09%)
UNITY 35.80 Increased By ▲ 0.87 (2.49%)
WTL 1.53 Increased By ▲ 0.08 (5.52%)
BR100 4,846 Increased By ▲ 46.43 (0.97%)
BR30 24,817 Increased By ▲ 123.55 (0.5%)
KSE100 45,175 Increased By ▲ 231.06 (0.51%)
KSE30 18,470 Increased By ▲ 86.89 (0.47%)

Coronavirus
VERY HIGH
Pakistan Deaths
18,797
12024hr
Pakistan Cases
854,240
410924hr
Sindh
290,756
Punjab
316,334
Balochistan
23,186
Islamabad
77,684
KPK
123,150
Business & Finance

China's CNBG has supplied 3 million COVID-19 vaccine doses to UAE

  • CNBG has moved into late-stage clinical trials two COVID-19 vaccine candidates respectively developed by its units in Beijing and Wuhan city
05 Jan 2021

BEIJING: United Arab Emirates (UAE) has received a total of three million COVID-19 vaccine doses from China National Biotec Group (CNBG), the company said on Tuesday.

CNBG has moved into late-stage clinical trials two COVID-19 vaccine candidates respectively developed by its units in Beijing and Wuhan city. The Beijing unit's shot obtained a green light last week for general public use in China.

CNBG is a subsidiary of state-backed China National Pharmaceutical Group (Sinopharm).

"According to preliminary feedback from UAE, emergency use shows that Sinopharm CNBG's COVID-19 vaccine is safe in large-scale use and has significantly reduced the disease in vaccinated people," CNBG said in an article published on Chinese social media WeChat, without specifying which candidate it referred to.

The firm didn't break down the numbers of doses for each candidate in its supply to UAE. It's not immediately clear how many of these doses were used in clinical trials and how many in real-life use.

Pakistan said last week it would purchase 1.2 million doses of the vaccine developed by CNBG's Beijing unit.